PDS Biotechnology Corporation PDSB
0.80
0.00
0.00%
as of 25 Sep
- Market cap
- $44.2M
- P/E
- 0.0×
Follow PDSB
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
2.09 | 2.98 | 2.26 | 0.57 |
Net Debt/EBITDA |
1.69 | 1.59 | 1.82 | 0.20 | |
Debt/Assets |
34.35% | 55.39% | 43.08% | 49.19% | |
Debt/Equity |
1.26 | 1.83 | 2.73 | (1.21) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.66 | 0.49 | 0.59 | 0.29 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.13) | (0.08) | (0.08) | (0.05) | |
Cash per Share |
0.56 | 0.58 | 0.39 | 0.10 | |
Shareholders Equity per Share |
0.20 | 0.20 | 0.07 | (0.06) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.20 | 0.20 | 0.07 | (0.06) | |
Free Cash Flow |
(5.92) | (3.70) | (4.37) | (2.79) | |
Working Capital |
14.56 | 18.77 | 12.74 | (5.33) | |
Net Current Asset Value |
2.64 | 7.01 | 2.12 | (5.34) | |
| Other line items | |||||
Quick Ratio |
1.97 | 2.82 | 2.13 | 0.45 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.13) | (0.08) | (0.08) | (0.05) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
3.24 | 2.63 | 3.25 | 5.45 | |
Average Assets |
43.58 | 37.93 | 35.85 | 24.64 | |
Average Common Equity |
15.73 | 14.13 | 13.13 | 6.19 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates